Add the ALS Society of Quebec to the list of non-profit organizations thinking outside of the box during these COVID-19 times. ALS is a neurodegenerative incurable fatal illness that destroys motor neurons. People with ALS gradually lose their mobility, but also their ability to talk, eat and eventually, breathe. Senses are not affected and 80 percent die within two to five years after the diagnosis. There are currently more than 500 Quebecers living with ALS.
It is known as Lou Gehrigâs disease after the baseball great who succumbed to ALS on June 2, 1941. For the past two years Major League Baseball has recognized this as âLou Gehrig Day.â Locally, former Expos, sports, media (including me) and entertainment personalities have united to Strike out ALS. Everyone is invited to take part in this initiative by sharing their stories, pictures and a message of hope through an impressive mosaic. They can also honor someone who is living with ALS, or a lost a loved one and
ALS Biomarkers in Drug Development, Upcoming Webinar Hosted by Xtalks
Share Article
In this free webinar, industry experts will provide an overview of different types of ALS biomarkers, how ALS biomarkers should be chosen based on the relevance to the mechanism of action and why their use in ALS trials should be a serious consideration. They will also discuss how some biomarkers in ALS research are more valuable than others at this time, as well as the application of ALS biomarkers in drug development.
There is a strong need for research, understanding and potential treatments in ALS. This webinar will focus on ALS biomarkers.
An MS diagnosis is tough to accept, but the treatment landscape is changing montrealgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montrealgazette.com Daily Mail and Mail on Sunday newspapers.
Pharma giant Sanofi Pasteur has poached Eleanor Duff from AstraZeneca to become its head of global comms.
by Jonathan Owen
Sign in to continue
Register
Limited Article Views (Excludes Subscriber Only Content)
Select Newsletters (Excludes Subscriber Only Bulletins)
Limited number of free email bulletins
Unlimited Access to PRWeek content
Daily Breakfast Briefing
PRWeek Daily News (subscriber-exclusive email bulletin)
Exclusive access to Power Book and Top 150 UK Consultancies/Agency Business Report content
PRWeek magazine delivered